1.
Kumar A, Prakash AS. Effectiveness and Safety of Hydroxychloroquine compared to Teneligliptin in uncontrolled T2DM patients as add-on therapy. J ASEAN Fed Endocr Soc [Internet]. 2019 Jul. 30 [cited 2024 Dec. 4];34(1):87. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/520